Smith & Wesson Q1 FY2027 Earnings: Sales Rise 32% as Profit Returns
Smith & Wesson reported fiscal Q1 2027 net sales of $112.6 million, up 32.3% year over year, with diluted GAAP EPS improving to $0.06. Operating income and net income returned to positive territory, aided by operating leverage and a non-recurring $2.9 million tariff refund that drove most of the gross margin expansion to 28.7%. However, rising inventory and increased capital expenditures widened the free cash flow deficit to $20.8 million. Management reaffirmed its full-year revenue growth outlook of 5% to 7%, while key risks include margin normalization, working-capital pressures, and cash flow management.
Smith & Wesson Brands (NASDAQ: SWBI) reported fiscal Q1 2027 net sales of $112.6 million, up 32.3% year over year, while diluted GAAP EPS improved to $0.06 from a loss of $0.08 for the quarter ended July 31, 2026. Gross margin increased to 28.7%, although a non-recurring tariff refund accounted for most of the expansion. Earnings returned to positive territory, but higher inventory and capital spending widened the free cash flow deficit.
Core Financial Results
Net sales increased by $27.5 million, while gross profit rose faster than revenue. Operating expenses increased by approximately 12.1%, substantially below the sales growth rate, reducing operating expenses to 24.9% of sales from 29.4% a year earlier.
The combination of higher sales, a tariff-related gross margin benefit, and operating leverage moved GAAP operating income and net income back into positive territory. Adjusted EBITDAS nearly doubled and its margin expanded by 350 basis points.
| Metric | Fiscal Q1 2027 | Fiscal Q1 2026 | YoY Change |
|---|---|---|---|
| Net sales | $112.6 million | $85.1 million | +32.3% |
| Gross profit / margin | $32.3 million / 28.7% | $22.1 million / 25.9% | +46.2% / +280 bps |
| Operating income / margin | $4.2 million / 3.7% | $(3.0) million / (3.5)% | Improved by about $7.2 million |
| GAAP net income | $2.6 million | $(3.4) million | Returned to profit |
| Diluted GAAP EPS | $0.06 | $(0.08) | Improved by $0.14 |
| Adjusted EBITDAS / margin | $13.8 million / 12.2% | $7.4 million / 8.7% | +85.7% / +350 bps |
| Operating cash flow | $(8.8) million | $(8.1) million | Outflow widened by $0.7 million |
| Free cash flow | $(20.8) million | $(12.4) million | Outflow widened by $8.4 million |
Smith & Wesson changed its Adjusted EBITDAS methodology beginning with its fiscal Q4 2026 presentation to account for both interest expense and interest income. The revised methodology reduced fiscal Q1 2027 Adjusted EBITDAS by $547,000 and the comparable prior-year amount by $632,000 relative to the former calculation.
A One-Time Tariff Refund Drove Most of the Margin Expansion
Smith & Wesson received $2.9 million in tariff refunds during the quarter. Management said the refunds increased gross margin by approximately 260 basis points and represented a non-recurring benefit.
Reported gross margin expanded by 280 basis points to 28.7%. On a simple basis, removing the disclosed refund effect would leave a margin of approximately 26.1%, only about 20 basis points above the prior-year level. This indicates that most of the reported margin expansion is unlikely to recur solely from the same factor.
The operating recovery was not entirely dependent on gross margin. Total operating expenses rose to $28.1 million from $25.0 million, but declined substantially as a percentage of sales because revenue grew faster. Net interest expense also fell to $0.3 million from $1.2 million, supporting the return to positive pre-tax income.
Profit Recovered, but Inventory and Capex Pressured Cash Flow
Operating cash outflow widened modestly despite the return to profitability. A $10.3 million reduction in accounts receivable helped cash generation, but inventory consumed $24.4 million and accrued payroll and incentives used another $8.6 million.
Capital expenditures increased to $11.9 million from $4.3 million, causing free cash flow to decline to negative $20.8 million. At July 31, inventory stood at $180.7 million, up from $156.3 million at the end of April, while cash and cash equivalents fell to $18.7 million from $28.2 million.
Notes and loans payable rose to $39.2 million from $19.1 million after the company received $20.0 million in financing proceeds. Smith & Wesson also distributed $6.0 million in dividends during the quarter, and its board subsequently authorized a quarterly dividend of $0.13 per share.
Earnings Guidance
Management maintained its full-year revenue outlook and expects fiscal Q2 sales to remain above the prior-year period. The guidance assumes a normal seasonal environment and continued demand across the company’s consumer and professional channels.
| Metric | Latest Guidance | Status |
|---|---|---|
| Fiscal Q2 2027 net sales growth | Roughly 10% above the prior year | Continued outlook |
| Fiscal 2027 revenue growth | Approximately 5%-7% over fiscal 2026 | Reaffirmed |
Although the CEO expects fiscal Q2 to outperform the prior year on both the top and bottom lines, the company did not provide quantified earnings guidance.
Management Perspective
CEO Mark Smith attributed the quarter’s sales growth to demand in both consumer and professional channels, as well as product innovation, industry partnerships, operating execution, and brand strength. CFO Deana McPherson said the company continues to expect normal seasonality and solid product demand, supporting the maintained annual revenue outlook.
Risks Investors Should Watch
- Gross margin normalization: The tariff refund supplied approximately 260 of the quarter’s 280 basis points of gross margin expansion. Its non-recurring nature creates a difficult comparison for subsequent quarters.
- Working-capital pressure: Inventory increased by $24.4 million during the quarter and reached $180.7 million, contributing to negative operating cash flow despite positive net income.
- Higher investment and borrowing: Capital expenditures nearly tripled year over year, while notes and loans payable increased by roughly $20 million from the end of April. Continued cash outflows could place greater importance on financing and working-capital management.
- Execution against demand assumptions: The fiscal Q2 and full-year revenue outlooks depend on continued consumer and professional demand and a normal seasonal environment.
Summary
Smith & Wesson’s fiscal Q1 2027 results showed a clear recovery in sales and earnings, supported by higher demand, operating leverage, and lower net interest expense. However, most of the gross margin expansion came from a non-recurring tariff refund, while rising inventory and capital spending deepened the free cash flow deficit. The main points to monitor are margin performance without the refund, inventory conversion, and whether demand remains sufficient to deliver the reaffirmed 5%-7% annual revenue growth outlook.
This article may include AI-generated content that is human-reviewed, which is for reference and general information purposes only and does not constitute investment advice.
Recommended Articles










Comments (0)
Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.